User profiles for Paari Murguan

Paari Murugan

University of Minnesota
Verified email at umn.edu
Cited by 1671

Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder

S Alanee, I Alvarado-Cabrero, P Murugan… - World journal of …, 2019 - Springer
Purpose To provide a comprehensive update of the joint consultation of the International
Consultation on Urological Diseases (ICUD) for the diagnosis and management of non-…

Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma

…, EJ Pietzak, JP Sfakianos, A Bagrodia, P Murugan… - Clinical Cancer …, 2019 - AACR
Purpose: To investigate genomic differences between urothelial carcinomas of the upper
tract (UTUC) and bladder (UCB), with a focus on defining the clonal relatedness of temporally …

Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing …

…, DJ Einstein, CB Dechet, WT Lowrance, PJ Murugan… - 2020 - ascopubs.org
439 Background: Cisplatin-based neoadjuvant chemotherapy (NAC) in MIBC improves
survival which correlates with pathologic response (PaR) at radical cystectomy (RC). The …

[HTML][HTML] Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief …

P Murugan, N Siddaraju, S Habeebullah… - Indian journal of …, 2009 - journals.lww.com
Background: The prognostic and therapeutic significance of differentiating adenocarcinoma
(AC) from reactive mesothelium (RM) in effusions cannot be overemphasized. To avoid …

Molecular characterization of neuroendocrine-like bladder cancer

…, S Gupta, P Grivas, KW Mouw, P Murugan… - Clinical cancer …, 2019 - AACR
Purpose: Neuroendocrine (NE) bladder carcinoma is a rare and aggressive variant.
Molecular subtyping studies have found that 5% to 15% of muscle-invasive bladder cancer (MIBC) …

3D printed organ models with physical properties of tissue and integrated sensors

…, R Su, Z Zhu, DB Bhuiyan, P Murugan… - Advanced materials …, 2018 - Wiley Online Library
The design and development of novel methodologies and customized materials to fabricate
patient‐specific 3D printed organ models with integrated sensing capabilities can yield …

Five new cases of primary renal carcinoid tumor: case reports and literature review

…, JA Albersheim, NJ Sathianathen, P Murugan… - Pathology & Oncology …, 2020 - Springer
Carcinoid tumors, a slow-growing NET, most commonly arise in the gastrointestinal tract (73.7%),
followed by the bronchopulmonary system (25.1%), and least commonly in the …

Fusion-driven spindle cell rhabdomyosarcomas of bone and soft tissue: a clinicopathologic and molecular genetic study of 25 cases

CA Dehner, SM Broski, JM Meis, P Murugan… - Modern Pathology, 2023 - Elsevier
The evolving classification of rhabdomyosarcoma (RMS) now includes spindle cell RMS (SRMS).
Bone/soft tissue SRMS often harbor TFCP2, or less often MEIS1 rearrangements. We …

Biomonitoring DNA adducts of cooked meat carcinogens in human prostate by nano liquid chromatography–high resolution tandem mass spectrometry: identification …

…, PW Villalta, S Krishna, R Tejpaul, P Murugan… - Analytical …, 2016 - ACS Publications
Epidemiologic studies have reported an association between frequent consumption of well-done
cooked meats and prostate cancer risk. However, unambiguous physiochemical …

[HTML][HTML] Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

…, W Tan, M Kohli, R Yang, AC Hsieh, P Murugan… - Nature …, 2021 - nature.com
Endocrine therapies for prostate cancer inhibit the androgen receptor (AR) transcription
factor. In most cases, AR activity resumes during therapy and drives progression to castration-…